KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kla (KLAC) Asset Writedowns and Impairment (2016 - 2024)

Kla (KLAC) has 9 years of Asset Writedowns and Impairment data on record, last reported at $239.1 million in Q4 2024.

  • For Q4 2024, Asset Writedowns and Impairment rose 9.18% year-over-year to $239.1 million; the TTM value through Jun 2025 reached $31.4 million, up 177.77%, while the annual FY2025 figure was $239.1 million, 2014.62% up from the prior year.
  • Asset Writedowns and Impairment reached $239.1 million in Q4 2024 per KLAC's latest filing, up from -$278.2 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $239.1 million in Q4 2024 and bottomed at -$278.2 million in Q2 2024.
  • Average Asset Writedowns and Impairment over 5 years is $27.1 million, with a median of $7.6 million recorded in 2021.
  • Peak YoY movement for Asset Writedowns and Impairment: tumbled 65.14% in 2020, then soared 589.25% in 2021.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at $865000.0 in 2020, then skyrocketed by 589.25% to $6.0 million in 2021, then soared by 53.57% to $9.2 million in 2022, then skyrocketed by 2291.87% to $219.0 million in 2023, then increased by 9.18% to $239.1 million in 2024.
  • Per Business Quant database, its latest 3 readings for Asset Writedowns and Impairment were $239.1 million in Q4 2024, -$278.2 million in Q2 2024, and $70.5 million in Q1 2024.